These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3135503)

  • 1. Dihydroergocryptine improves behavioral deficits of aged male rats.
    Drago F; Valerio C; D'Agata V; Lauria N; Scapagnini U
    Neurobiol Aging; 1988; 9(3):285-90. PubMed ID: 3135503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
    Flório JC; Palermo-Neto J
    Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroergocristine and memory alterations of aged male rats.
    Drago F; Valerio C; Scalisi B; D'Agata V; Scapagnini U
    Pharmacol Biochem Behav; 1988 Aug; 30(4):961-5. PubMed ID: 3147464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroergocriptine in management of microprolactinomas.
    Faglia G; Conti A; Muratori M; Togni E; Travaglini P; Zanotti A; Mailland F
    J Clin Endocrinol Metab; 1987 Oct; 65(4):779-84. PubMed ID: 3116032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroergocristine improves behavioral deficits of aged rats.
    D'Agata V; Spadaro F; Drago F
    Pharmacol Res Commun; 1988 Dec; 20(12):1119-20. PubMed ID: 3145509
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
    Banasikowski TJ; Beninger RJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid liposomes potentiate the inhibitory effect of antidepressant drugs on immobility of rats in a despair test (constrained swim).
    Drago F; Continella G; Mason GA; Hernandez DE; Scapagnini U
    Eur J Pharmacol; 1985 Sep; 115(2-3):179-84. PubMed ID: 4065207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and neurochemical effects of dopaminergic drugs in models of brain injury.
    Medico M; De Vivo S; Tomasello C; Grech M; Nicosia A; Castorina M; D'Agata MA; Rampello L; Lempereur L; Drago F
    Eur Neuropsychopharmacol; 2002 Jun; 12(3):187-94. PubMed ID: 12007669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine versus haloperidol catalepsy in the rat: a behavioral analysis of postural support mechanisms.
    De Ryck M; Schallert T; Teitelbaum P
    Brain Res; 1980 Nov; 201(1):143-72. PubMed ID: 7191346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential attenuation of some effects of haloperidol in rats given scopolamine.
    Setler P; Sarau H; McKenzie G
    Eur J Pharmacol; 1976 Sep; 39(1):117-26. PubMed ID: 986946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol differentially potentiates tonic immobility, the dorsal immobility response, and catalepsy in the developing rat.
    Meyer ME; Smith RL; Van Hartesveldt C
    Dev Psychobiol; 1984 Jul; 17(4):383-9. PubMed ID: 6745499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a Palicourea marcgravii leaf extract on some dopamine-related behaviors of rats.
    Górniak SL; Palermo-Neto J; de Souza-Spinosa H
    J Ethnopharmacol; 1990 Mar; 28(3):329-35. PubMed ID: 2335961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of deprenyl in aged rats.
    Drago F; Continella G; Spadaro F; Cavaliere S; Scapagnini U
    Funct Neurol; 1986; 1(2):165-74. PubMed ID: 3111946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK; Weinberger DR
    Brain Res Dev Brain Res; 1993 Oct; 75(2):213-22. PubMed ID: 7903225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in catalepsy response in inbred rats during chronic haloperidol treatment is not predictive of the intensity of behavioral hypersensitivity which subsequently develops.
    Kinon BJ; Kane JM
    Psychopharmacology (Berl); 1989; 98(4):465-71. PubMed ID: 2505286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
    Kobayashi T; Araki T; Itoyama Y; Takeshita M; Ohta T; Oshima Y
    Life Sci; 1997; 61(26):2529-38. PubMed ID: 9416775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and haloperidol-induced versus handling-related catalepsy in male rats.
    De Ryck M; Hruska RE; Silbergeld EK
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1027-35. PubMed ID: 7178196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
    Melo LL; Santos P; Medeiros P; Mello RO; Ferrari EA; Brandão ML; Maisonnette SS; Francisco A; Coimbra NC
    Brain Res; 2010 Aug; 1349():41-7. PubMed ID: 20558148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
    Dhingra D; Goswami S; Gahalain N
    Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.